Join us at our (invite-only!) Innovation Summits—where bold ideas meet cutting-edge technology.
As part of our innovation strategy, we’re consistently talking to our customers and to the market to understand where the biggest data challenges exist and where we could best support via technology over the years to come.
We are hosting Innovation Summits on the East and West coast this fall where we gather input from Sponsor teams in translational research, biomarker / biospecimen operations, data science, R&D IT, bioinformatics, and others.
We’d love to welcome you to attend and share your perspective and feedback!
Innovation Summit agenda:
You’ll enjoy an afternoon of engaging sessions and hands-on interactions with our Precision Medicine AI Agents to elevate your thinking and keep you at the forefront of innovation. Your insights will help shape the next peak of QuartzBio’s evolution.
Connect with industry experts, peers, and fellow users as you explore the latest platform updates, discover best practices, and get a sneak peek at what’s ahead on the QuartzBio roadmap—empowering your day-to-day work.
Request your invite:
If you’d like to attend or learn more about these events, please reach out to our sales team and we’ll be happy to provide you with invite details.
At this interactive event, Amazon Web Services (AWS) partner organizations will explore how GenAI is reshaping the future of health — from bench to bedside.
Tobi Guennel, Ph.D., QuartzBio’s Chief Technology Officer, will present use cases showing how R&D organizations are leveraging agentic frameworks and multi-agent networks to scale GenAI’s impact on every aspect of precision medicine development.
https://www.quartz.bio/wp-content/uploads/2025/09/QB_LInkedin_AWS-Speaker_1200x1200.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2025-09-24 13:29:182025-09-24 13:29:19GenAI Roadmap: Transforming the Future of Healthcare & Life Sciences
Attending the BiotechX USA conference in Philadelphia? It’s the premier conference for R&D teams who understand the impact of digital transformation across the entire precision medicine value chain.
Stop by booth #603 to chat with QuartzBio’s Precision Medicine AI Agents. We’ll demonstrate how our AI agents act as secure, personalized virtual assistants, delivering Sample and Biomarker Intelligence Solutions for translational research, informatics, sample/biomarker operations, and IT teams.
These agents help you with everyday tasks such as finding data, answering questions, surfacing analytics, and prescriptive recommendations for risk-mitigating actions.
See how you can unlock 10X faster access to insights and a >2X boost in team productivity, accelerating study close and time-to-market.
https://www.quartz.bio/wp-content/uploads/2025/08/QB_LInkedIn_BioTechX2025_1200x1200_Blue.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-09-15 13:45:282025-09-15 13:46:29Join QuartzBio at BiotechX 2025: Explore Precision Medicine AI Agents
On Demand
Duration: 30 minutes
Sign up to watch the webinar on demand:
What you’ll learn:
Your team is tasked with data storytelling.
Every day, you’re pressed to turn complex biomarker, clinical, and sample datasets into actionable insights. To stay competitive, your team needs to report findings in minutes, not hours or weeks.
Unlock the speed you need with QuartzBio’s Precision Medicine AI Agents, which power our Biomarker and Sample Intelligence solutions by serving as secure, personalized assistants for stakeholders across the entire precision medicine value chain. They deliver 10x faster* insights within a unified, self-serve platform, amplifying the impact of every team member.
Join Bill Hall as he chats with these AI Agents, showing how generative AI saves time and powers collaboration across multiple teams:
Faster Operations: e.g., 10X faster identification of consented samples with mutation data, split by treatment arm
Faster Informatics & Data Management: e.g., automatic data ingestion, QC, and mapping; application of FAIR principles, access control, and automated workflows
Faster Translational Research: e.g., in minutes, perform statistical analyses of assay data, incorporating clinical metadata and contextual information
You’ll learn how QuartzBio’s approach transforms the way precision medicine teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
**QuartzBio internal study, comparing Agent Intelligence to traditional workflows and point solutions, as determined via time-motion analysis.
https://www.quartz.bio/wp-content/uploads/2025/08/QB_LinkedIn_Webinar-SEPT2025_1200x1200_-VOD_Orange.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2025-08-08 13:27:532025-09-15 13:10:48Webinar — AI Agents in Action: 10X Faster Insights Across the Precision Medicine Ecosystem
Missed our presentation at Bio-IT World?
Watch Tobi Guennel, Ph.D., QuartzBio’s Co-founder and Chief Technology Officer, demonstrate how a network of domain-specific AI agents, orchestrated by our first-in-class Precision Medicine Virtual Assistant, empowers informatics, translational, and IT teams to conversationally explore and visualize clinical, sample, and biomarker data. The Precision Medicine AI Agent network can perform tasks semi-autonomously based on expected events and observed data trends.
You’ll see how you can get from data to insights by generating analytics and visualizations in minutes instead of hours or days — accelerating study close and time-to-market.
https://www.quartz.bio/wp-content/uploads/2025/09/LinkedIn_BioIT2025_Im-Speaking_B.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-04-16 16:20:002025-09-26 16:25:54The Precision Medicine AI Agent Network: Intelligence at Scale
Duration: 30 minutes, on demand
Sign up to watch the webinar:
What you’ll learn:
R&D teams in biomarker-rich clinical trials are constantly chasing insights around a complex data ecosystem. By the time stakeholders find their data, gain access, ideate on the right analysis and get results, the chance to make impactful decisions may be over.
Domain-specific AI agents, orchestrated by our Precision Medicine Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data.
Join Bill Hall as he chats with the Virtual Assistant, conversationally extracting insights in seconds, achieving:
Amplified Operational Efficiency: e.g., “Show me biopsy samples from patients in the 70th percentile of JAK2 expression at baseline”
Autonomous Workflows & Interoperability: e.g., automatically ingesting and harmonizing assay data upon arrival from testing lab
Amplified Translational Research: e.g., ““Compare gene expression profiles for responders vs non-responders at baseline”
You’ll learn how QuartzBio’s approach transforms the way precision medicine teams work with 360° intelligence.
Who should attend:
Translational Scientists
Biomarker Operations and Biospecimen Operations Teams
https://www.quartz.bio/wp-content/uploads/2025/04/LinkedIn_MAY-Webinar_1200x1200_Grey-A-2.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-04-11 13:34:422025-05-22 12:39:13Webinar: Precision Medicine AI Agents Accelerate Data-to-Insights
The promise of precision medicine starts with the sample data value chain.
Sample Data Value Chain: From Site to Result
This value chain was the focus of an exciting session at the 2025 SCOPE Summit for Clinical Operations Executives, where biospecimen operations, biomarker operations, and clinical operations teams shared how sample management practices lead directly to increased quality, speed, and reproducibility of research and development.
This year’s SCOPE conference stood out in a few notable ways:
In an industry first, biopharma sponsors joined forces to pursue standardized and interoperable systems, processes, and ecosystems for connecting the sample data value chain.
More data scientsts and leaders of IT functions attended the conference than ever, indicating that technology and data is playing and will play a key role for the future of clinical and sample operations.
QuartzBio’s Tobi Guennel, PhD, inspired lively discussion in his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI.”
He explored the opportunities for technology to empower the people and processes across the entire sample data value chain, addressing:
The importance of the sample data value chain within the Precision Medicine Value Chain
Benefits of connecting data across the entire sample data value chain instead of focusing on individual links of the chain
How a platform approach, leveraging a domain-specific Precision Medicine AI Agent Network, enables seamless data ingestion and real-time sample intelligence across the value chain
https://www.quartz.bio/wp-content/uploads/2025/03/LInkedin_Watch-Video_SCOPE2025_2.jpg12001200Chandreyee Dashttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgChandreyee Das2025-03-03 16:45:022025-03-03 16:45:04From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI
Ask a question, get an answer, and gain valuable insights across the precision medicine data ecosystem.
Powered by the first network of Precision Medicine AI Agents.
Supercharges the day-to-day work of translational researchers, data scientists, and informatics teams.
Join Bill Hall as he chats with QuartzBio’s Virtual Assistant, conversationally extracting insights in seconds with questions such as:
“Which mutations have highest prevalence at baseline?”
“Which subjects are in the 70th percentile of JAK2 expression at baseline and have stored, consented, baseline samples?”
“What is the correlation of JAK2 and STAT1 expression at baseline across samples?”
You’ll discover QuartzBio’s approach, which employs smart, automated integration of biomarker, sample, and clinical data to create a unified data ecosystem – now amplified with the power of conversational interactions to enable more consumable insights, regardless of your data expertise.
Who should attend:
Translational Scientists Data Science and Bioinformatics Teams R&D Information Technology (IT)
https://www.quartz.bio/wp-content/uploads/2024/07/Linkedin_Webinar-SEPT2024_Empowering-PM-with-Conversational-AI_On-Demand_Update.jpg12001200QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2024-07-26 19:14:102025-07-25 17:11:08Webinar: Empowering Precision Medicine with Conversational AI — A New Era of Biomarker Intelligence
“Harnessing Insights Across Clinical Trials with the Power of Conversation” — a presentation by Tobi Guennel, Ph.D., head of product development and innovation at QuartzBio
Watch the recording of the presentation:
Summary:
Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference.
Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development.
“It’s great to have a clinical trials-focused session at Bio-IT World, and being able to share success stories, especially about AI, in this landscape,” said Guennel. “We are firm believers that iteration and collaboration can only improve technology and create new paths for innovation.”
Guennel’s narrative centered around QuartzBio’s Precision Medicine AI Agent Platform, powered by AI, which allows precision medicine development teams to extract the most value from clinical trial samples and exploratory biomarker data.
“One benefit of natural language understanding capabilities of conversational AI is that a broad range of user personas, with diverse roles and functions, can interact with and extract insights from a unified, singular data ecosystem of sample and biomarker data.
Teams such as data science, translational research, and biosample or biomarker operations can now interrogate a unified data asset using natural language.”
Considerations for developing a large language model (LLM) ecosystem for precision medicine
To build a solid GAI framework to enable our sample and biomarker intelligence products, the QuartzBio team asked themselves:
What LLMs are needed to support our domain and the tasks performed through the components of our products?
How can we integrate these models into a scalable GAI workflow to support user stories and workflows without having to re-invent the wheel as we move from use case to use case?
QuartzBio’s Precision Medicine AI Agent Platform, formerly called the Biomarker Intelligence Platform, powered by AI: An ecosystem of domain- and task-specific small LLMs trained by fine-tuning existing foundational models (FMs). LLMs support the data management layer of the platform, the business intelligence layer to support conversational and prescriptive AI insights, and the overarching navigational AI component to enhance user experience and adoption.
Considerations for developing individual LLMs:
LLM Development
Leverage existing Foundational Models: Start with existing powerful language models that are right-sized.
Fine-Tuning: Customize these models for specific domains and tasks.
Small LLMs: Create smaller, specialized models for targeted applications for improved cost/accuracy.
GAI Integration
Prompt Engineering: Design tailored prompts to guide LLM behavior based on supported tasks.
Leverage RAG: Combine LLMs with retrieval mechanisms for enhanced performance.
User Agents: Implement user-specific agents to optimize model interactions and leverage live data.
Benefits
Precision: Fine-tuned LLMs provide accurate and context-aware responses for specific tasks.
Supporting the entire precision medicine lifecycle
QuartzBio is integrating this GAI framework seamlessly into its Biomarker Intelligence platform to support a broad range of user stories and flows with a suite of SaaS products.
Sponsors are using the platform and products to build an interconnected data asset and, subsequently, draw insights via QuartzBio’s Biomarker Intelligence tools powered by conversational AI.
Sponsors leverage the platform as a force multiplier by creating internal efficiencies. Their teams are free to focus on insight generation rather than data wrangling.
Further, the QuartzBio platform amplifies knowledge by centralizing information and insights and making these easily consumable by a wide range of stakeholders. Ultimately, this increased access to intelligence enables sponsor teams to advance Precision Medicine objectives, such as accelerating patient selection strategies, identifying drug targets, and driving clinical trial efficiency.
Learn more: Watch a demo of QuartzBio’s AI-powered platform
Join the next webinar demonstration of our platform by signing up on our Webinars & Events page! We’ll invite you to our next webinar, and meanwhile you can watch one of our recent demos on demand.
https://www.quartz.bio/wp-content/uploads/2024/08/QB_BIOIT_PRES_Tobi_Followup_04242024.jpg10801080QuartzBio Teamhttps://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svgQuartzBio Team2024-04-23 15:30:242025-03-26 10:58:06AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024
Last week, biomarker intelligence leaders from Boston-area R&D organizations got a firsthand look at the powerful predictive and prescriptive intelligence that will soon infuse QuartzBio’s AI Biomarker Intelligence Platform, after sharing common challenges facing data-rich precision medicine clinical programs.
Even though our guests represented organizations that varied in size, number of clinical trials, and therapeutic area, they all shared the challenges of disconnected technology and data ecosystems. Over three million data points are generated per clinical trial and over 70% of that data comes from labs. Sponsor organizations are realizing that they are missing opportunities to advance precision medicine if they do not address their data and technology challenges.
Guest speaker and AI expert, Srivatsan Nagaraja, described the potential of generative AI (GAI) and large language models to overcome these challenges and speed decision-making; not surprisingly, 76% of biopharma companies are investing in AI.
Srivatsan left the audience with two takeaways:
“Generative AI is not going away – and the journey is as important as the destination.”
The journey, in this context, refers to
How the GAI model is trained and prompted – ideally, by subject matter experts and domain-specific knowledge, iteratively improving the value derived from AI
The quality, structure, and format of the underlying data
The QuartzBio team gave a quick demo of their AI-powered Biomarker Intelligence Platform, showing guests how they could get a 360° look around their sample ecosystem in seconds.
We wrapped up the Biomarker Intelligence Summit with a networking happy hour and hands-on exploration stations. Guests interacted with QuartzBio’s conversational AI Virtual Assistant, experiencing how it could help derive valuable insights quickly and easily.
Have a burning question for our team and/or the QuartzBio AI Virtual Assistant?
